News NHS may double subscription rate for novel antibiotics The yearly subscription-style payments made by NHS England to developers of novel antibiotics could be doubled from £10 million to £20 million in some cases, according to
Oncology ASCO 2023 – Dr Lalan Wilfong In the last video from ASCO 2023, we step away from the R&D side to talk about drug costs and payment models.
Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics.
Patients The need for a science-first mindset: The vaccine landscape ... In a new pharmaphorum podcast, Rebecca Catterick, General Manager for Vaccines, UK & Ireland, at Sanofi, discusses the decline in vaccination rates.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.